HOLX : Analysis & Opinions

  1. Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst ...

    December 17, 2014
    Developer of genomic-based clinical laboratory services, Genomic Health Inc. (GHDX) recently announced positive feedback ...
  2. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  3. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  4. Hologic Struggling To Find A New Path

    August 7, 2013
    Hologic is struggling to become a growth company again, and the new CEO may find his options limited.
  5. Recent Financials May Not Be Entirely Fair To Hologic

    May 8, 2013
    Macro pressures are outweighing solid internal progress at Hologic.
  6. How Far Can Philips' Turnaround Take The Stock?

    December 13, 2012
    Philips has improved, but can it be a truly top-notch company?
  7. Time For Hologic To Translate Technology Into Results

    November 14, 2012
    Hologic has to take market-leading technology and translate it into strong cash flow.
  8. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

    May 22, 2012
    Agilent is paying up to get into the increasingly crowded diagnostics market.
  9. HOLX / GPRO Deal Could Be Good for CUR - Analyst Blog

    May 1, 2012
    HOLX / GPRO Deal Could Be Good for CUR - Analyst Blog
  10. Philips – Plenty Of Cloud, Minimal Silver Lining

    January 11, 2012
    Koninklijke Philips suffers through yet another poor quarter.
  11. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  12. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  13. Philips Needs A Shake-Up

    June 23, 2011
    Philips badly needs to reform and rebuild its operations.
  14. Hologic Holding The Line

    May 4, 2011
    Hologic lacks exciting growth, but the technology is in place for better growth in the future.
  15. Cooper: A Growing Play On Eye Care

    December 10, 2010
    Cooper is continuting to grow very well in a tough healthcare market, and shows signs of a shining future.
  16. Time For A Diagnostics Test (VIVO, CYTC, MYGN)

    October 4, 2007
    Put the million-dollar research of a biotech ETF to work for you - for free.
  17. Get a Booster Shot with Health Care ETFs

    March 9, 2007
    A look at the recent offering of niche health care ETFs from Xshares Advisors.
Trading Center